
CVS Health Launches Second Annual In-Store Campaign to Support Stand Up To Cancer's Groundbreaking Cancer Research
CVS Health has announced the launch of its second annual in-store fundraising campaign to benefit Stand Up To Cancer, a program of the Entertainment Industry Foundation.
PRESS RELEASE
WOONSOCKET, R.I., Nov. 2, 2015 /PRNewswire/ --
Now through November 28, CVS/pharmacy customers can support SU2C in stores nationwide by making a $1 or $3 donation at the register or by donating online at
"We're so proud to collaborate with Stand Up To Cancer to positively impact people living with cancer," said Helena Foulkes, President, CVS/pharmacy. "Joining our colleagues and customers in supporting this groundbreaking research is a great extension of CVS Health's purpose of helping people on their path to better health."
The campaign will include in-store radio spots featuring Eva Longoria, which will remind shoppers that nearly 1.65 million Americans will be diagnosed with cancer this year, that there are more than 200 different types of cancer and that one in two men and one in three women will be diagnosed with cancer in their lifetimes.
"We are making progress in the fight to turn cancer patients into cancer survivors, but with more than 1,600 people in the U.S. dying from cancer each day, there is still a great deal more that needs to be done," said SU2C Co-founder Sue Schwartz. "We are incredibly grateful to CVS Health for giving people an easy way to make a donation to help advance our mission and remind everyone that it takes all of us to beat cancer."
In September, CVS Health and SU2C announced a print, radio and digital public service announcement campaign, entitled "It's Impossible to Beat Cancer Alone," aimed at bringing awareness to the importance of collaboration in the fight against cancer and to encourage the general public to learn more and get involved.
For more information on Stand Up To Cancer, visit
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.